Verrica Pharmaceuticals Inc.
VRCA · NASDAQ
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Assets | – | – | – | – |
| Cash & Equivalents | $46 | $70 | $34 | $16 |
| Short-Term Investments | $0 | $0 | $0 | $55 |
| Receivables | $0 | $4 | $0 | $0 |
| Inventory | $2 | $1 | $0 | $0 |
| Other Curr. Assets | $2 | $3 | $4 | $4 |
| Total Curr. Assets | $51 | $78 | $39 | $74 |
| Property Plant & Equip (Net) | $3 | $4 | $5 | $6 |
| Goodwill | $0 | $0 | $0 | $0 |
| Intangibles | $0 | $0 | $0 | $0 |
| Long-Term Investments | $0 | $0 | $0 | $0 |
| Tax Assets | $0 | $0 | $0 | $0 |
| Other NC Assets | $0 | $0 | $0 | $0 |
| Total NC Assets | $3 | $4 | $6 | $6 |
| Other Assets | $0 | $0 | $0 | $0 |
| Total Assets | $54 | $82 | $45 | $80 |
| Liabilities | – | – | – | – |
| Payables | $2 | $2 | $1 | $1 |
| Short-Term Debt | $14 | $1 | $0 | $42 |
| Tax Payable | $0 | $0 | $0 | $0 |
| Deferred Revenue | $0 | $0 | $0 | $0 |
| Other Curr. Liab. | $14 | $14 | $3 | $3 |
| Total Curr. Liab. | $29 | $17 | $3 | $46 |
| LT Debt | $32 | $45 | $1 | $1 |
| Deferred Rev, NC | $0 | $0 | $0 | $0 |
| Deferred Tax Liab, NC | $0 | $0 | $0 | $0 |
| Other NC Liab. | $3 | $0 | $0 | $0 |
| Total NC Liab. | $35 | $45 | $1 | $1 |
| Other Liabilities | $0 | $0 | $0 | $0 |
| Cap. Leases | $2 | $3 | $2 | $2 |
| Total Liabilities | $64 | $62 | $5 | $48 |
| Equity | – | – | – | – |
| Pref Stock | $0 | $0 | $0 | $0 |
| Common Stock | $0 | $0 | $0 | $0 |
| Retained Earnings | -$307 | -$230 | -$163 | -$139 |
| AOCI | $0 | $0 | $0 | -$0 |
| Other Equity | $297 | $250 | $203 | $172 |
| Total Equity | -$10 | $20 | $40 | $33 |
| Supplemental Information | – | – | – | – |
| Minority Interest | $0 | $0 | $0 | $0 |
| Total Liab. & Tot. Equity | $54 | $82 | $45 | $80 |
| Net Debt | -$0 | -$24 | -$33 | $28 |